mynth
← DATABASE
10/2016100%

Sarquavitae acquired by Domusvi

SPAIN Health Providers / Healthcare Facilities / Nursing Homes EV €300–700M

Context

DomusVi has successfully acquired its Spanish competitor SARquavitae, previously held by a consortium of investment funds including Palamon Capital Partners and G Square Capital. This transformative build-up operation allows the group to become the number one player in the Spanish elderly care market. The strategic rationale centers on geographic diversification, as the target’s strong footprint in Catalonia and Madrid perfectly complements the acquirer’s existing position in Galicia. The integration adds 88 facilities and 11,000 beds to the group’s portfolio, bringing total pro forma revenues to approximately €1.2 billion. This acquisition marks a significant milestone in the group’s international expansion strategy, following the previous year’s integration of another Spanish operator, thereby solidifying its leadership position in Southern Europe.

Sarquavitae, which reported an EBITDA margin of [members only] in 2016, is valued in this transaction at an EV/EBITDA multiple of 10x–18x.

-> Deep-dive in Healthcare & Pharma market trends

Target

SARquavitae is a leading Spanish provider of elderly care services, operating an extensive network of 88 facilities with a total capacity of 11,000 beds. The entity maintains a particularly strong strategic presence in key regions including Catalonia and Madrid, complementing its historical operations. Its business model focuses on residential care and specialized medical services for the dependent elderly population. The company provides high-quality clinical and hospitality services, positioning itself as a primary competitor in the Iberian long-term care market. By integrating advanced healthcare management protocols, the group ensures a stable value proposition for both private residents and public regional healthcare systems. The organization has demonstrated consistent growth and operational stability, making it a pivotal asset for consolidation in the European healthcare infrastructure landscape.

Ent. Value

€300–700M

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2016
€250–500M
€25–50M
[members only]
2015
€250–500M
€25–50M
[members only]

Other operations with Domusvi

Other operations with Domusvi
DateAcquirerTargetCountrySector
04/2021ICG / MANAGEMENT & PRIVATE INVESTORSDOMUSVIFRANCENursing Homes
03/2019DOMUSVIRESIDALYAFRANCENursing Homes
06/2017ICG / MANAGEMENT & PRIVATE INVESTORSDOMUSVIFRANCENursing Homes
06/2014PAI PARTNERSDOMUSVIFRANCENursing Homes

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
01/2017MARSVCAUNITED STATESVet Clinics
01/2017PARTNERS GROUP / PSP INVESTMENTSCERBA HEALTHCAREFRANCELabs (Biology)
05/2016VCACOMPANION ANIMAL PRACTICESUNITED STATESVet Clinics
03/2016F2I SGR / CIR - COMPAGNIE INDUSTRIALI RIUNITEKOS GROUPITALYNursing Homes
02/2016OMERSFOREFRONT DERMATOLOGYUNITED STATESOutpatient Care
08/2015CINVENSYNLABGERMANYLabs (Biology)
07/2015ANTIN INFRASTRUCTUREAMEDESGERMANYLabs (Biology)
05/2015CINVENLABCOFRANCELabs (Biology)
04/2015SUMMIT PARTNERS / VAM INVESTMENTSDENTALPROITALYDental Centers
01/2015CERBA HEALTHCARENOVESCIAFRANCELabs (Biology)

REFERENCES

Valuation range: EV €300–700M

Revenue range: €250–500M

EBITDA range: €25–50M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Sarquavitae by Domusvi are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Domusvi’s acquisition of 100% of Sarquavitae, a Spanish company specialised in Healthcare Facilities, in 2016.

How was the acquisition of Sarquavitae by Domusvi valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €300–700M band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Sarquavitae’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Sarquavitae generated annual revenue estimated in the €250–500M range and EBITDA in the €25–50M bracket (FY 2016). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction intelligence is supported by independent reporting from specialized financial publications, alongside a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.